A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer
Clinical trial NCT06308406 · UNKNOWN
Trial details
- NCT number
- NCT06308406
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2025-10-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.